These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6038188)

  • 21. Pacemaker protection against fatal arrhythmia in experimental acute coronary occlusion.
    Hatcher CR; Exarhos N
    Am Surg; 1966 Nov; 32(11):794-7. PubMed ID: 5926857
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on the development of ventricular fibrillation in experiments with temporary occlusion of the coronary artery. II].
    Wojtowicz M; Dybicki J; Zawistowski S; Wrzolek S; Bartoszewicz T
    Pol Arch Med Wewn; 1965; 35(5):681-3. PubMed ID: 5833731
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of anesthetization of A-V node on ventricular fibrillation following acute coronary arterial occlusion.
    WEBB WR; FIELD SE
    Am J Physiol; 1958 Nov; 195(2):403-6. PubMed ID: 13583184
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanical ventricular assistance for circulatory support in acute coronary artery occlusion in the pig: the Anstadt cup.
    Hoffer RE; Almond CH; Elefson EE; Anido H; Mackenzie JW
    Dis Chest; 1968 Apr; 53(4):502-6. PubMed ID: 5652486
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective release of catecholamines in experimental coronary occlusion.
    Ng KK; Wan SH; Ong SC
    Singapore Med J; 1973 Sep; 14(3):353-5. PubMed ID: 4777902
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenesis of ventricular fibrillation in coronary occlusion. Perfusion of coronary arteries with serum.
    DANESE C
    JAMA; 1962 Jan; 179():52-3. PubMed ID: 13883368
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence that serum potassium is not the etiological agent in ventricular fibrillation following coronary artery occlusion.
    WEXLER J; PATT HH
    Am Heart J; 1960 Oct; 60():618-23. PubMed ID: 13784686
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dynamics of the change in pCl of the myocardium during ischemia].
    Onishchenko NA; Sarukhanova EP; Rastorguev BP; Kogan IaA
    Biofizika; 1967; 12(4):648-51. PubMed ID: 5622224
    [No Abstract]   [Full Text] [Related]  

  • 29. [Coronary perfusion with oxygenated blood in preventing ventricular fibrillation during intracardiac surgery].
    HO TC; HSU CS; FANG TW; WU SJ; MAIO CH; KAO CS
    Zhonghua Wai Ke Za Zhi; 1960 Mar; 8():217-9. PubMed ID: 14402116
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of the substitute fluids on hyperemic ventricular fibrillation in the dog. V].
    Wojtowicz M; Dybicki J; Wrzolek S; Bartoszewicz T
    Pol Arch Med Wewn; 1966; 36(6):843-6. PubMed ID: 5911411
    [No Abstract]   [Full Text] [Related]  

  • 31. Ventricular fibrillation in dogs after sudden return of flow to the coronary artery.
    SEWELL WH; KOTH DR; HUGGINS CE
    Surgery; 1955 Dec; 38(6):1050-3. PubMed ID: 13274263
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of epicardiectomy on myocardial blood flow.
    King RD; Steiner SH; Heimburger IL
    J Thorac Cardiovasc Surg; 1966 May; 51(5):660-6. PubMed ID: 5931359
    [No Abstract]   [Full Text] [Related]  

  • 33. [VENTRICULAR FIBRILLATION IN TEMPORARY OCCLUSION OF THE CORONARY ARTERY].
    WOJTOWICZ M; DYBICKI J; ZAWISTOWSKI S; BARTOSZEWICZ T; WRZOLEK S
    Pol Arch Med Wewn; 1965; 35():377-82. PubMed ID: 14334427
    [No Abstract]   [Full Text] [Related]  

  • 34. [The antifibrillary properties of hydrazine derivatives in experimental acute coronary insufficiency].
    Popova NK
    Farmakol Toksikol; 1966; 29(1):44-7. PubMed ID: 5988615
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental coronary artery occlusion: ventricular fibrillation and survival as affected by selected drugs and ionic alterations.
    WILLIAMS WT; MEENA AL; TURNER MD; HARDY JD
    Dis Chest; 1958 Sep; 34(3):317-29. PubMed ID: 13574041
    [No Abstract]   [Full Text] [Related]  

  • 36. [Artificial circulation in acute coronary occlusion].
    Skorik WI; Balljuzek FW
    Cor Vasa; 1966; 8(3):208-14. PubMed ID: 5914861
    [No Abstract]   [Full Text] [Related]  

  • 37. Technology and laboratory investigation of perfusion and transfusion techniques.
    Busch U
    Z Kardiol; 1987; 76 Suppl 6():43-7. PubMed ID: 3326313
    [No Abstract]   [Full Text] [Related]  

  • 38. Segmental perfusion of the coronary arteries with fibrinolysin in man following a myocardial infarction.
    BOUCEK RJ; MURPHY WP
    Am J Cardiol; 1960 Aug; 6():525-33. PubMed ID: 13803175
    [No Abstract]   [Full Text] [Related]  

  • 39. The significance of postmortem coronary arterial perfusion studies.
    Vasko JS; Sabiston DC
    Am Heart J; 1966 Jun; 71(6):775-8. PubMed ID: 5945141
    [No Abstract]   [Full Text] [Related]  

  • 40. [Optimal coronary perfusion. 1. Experimental studies (devices and methods)].
    Matsumoto M
    Nihon Kyobu Geka Gakkai Zasshi; 1976 Dec; 24(12):1614-21. PubMed ID: 1035606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.